The Massachusetts R&D Tax Credit, governed by M.G.L. c. 63, § 38M and detailed in 830 CMR 63.38M, provides businesses with a nonrefundable (except for certified life sciences companies) tax credit for qualified research expenses (QREs) conducted in the state. Modeled closely after the federal IRC § 41 credit, it encourages innovation in sectors like life sciences, technology, and manufacturing by offsetting corporate excise tax liabilities through the Massachusetts Department of Revenue (DOR). Available to corporations subject to the corporate excise and owners of flow-through entities, the credit applies only to in-state research activities.
Eligibility mirrors federal IRC § 41 but requires activities and expenses tied to Massachusetts facilities. Businesses must conduct qualified research—developing or improving products, processes, software, or techniques with technological uncertainty.
Massachusetts offers two calculation methods: the Regular Method (incremental over a base amount) and the Alternative Simplified Credit (ASC), which simplifies the base for businesses with fluctuating expenses. Both use only Massachusetts-sourced QREs and gross receipts (or federal with election). Elections, such as using state-only gross receipts, are binding for three years.
Massachusetts tailors its R&D credit to support high-innovation sectors like life sciences, alongside separate MLSC tax incentives and capital programs.
A Massachusetts life sciences startup recovered $150,000 in state R&D credits through optimized ASC election and life sciences refund application.
The Massachusetts Research Credit offers 10% on excess qualified research expenses over the base amount, plus 15% for basic research payments, under M.G.L. c. 63, § 38M. Limited by excise caps but with indefinite carryforward for disallowed portions. Strike Tax maximizes your claim.
Activities must meet IRC § 41 standards—technological in nature, eliminating uncertainty in products or processes—and be conducted at Massachusetts facilities. Examples include software development or biotech prototyping. Strike Tax identifies qualifying projects.
For $1 million in incremental QREs, you could save $100,000, plus federal stacking. Life sciences firms often exceed this via refunds. Use Strike Tax’s R&D Credit Calculator for personalized estimates.
Generally nonrefundable, but certified life sciences companies can elect refunds through the Massachusetts Life Sciences Center. Unused credits carry forward 15 years or indefinitely for cap-disallowed amounts. Strike Tax navigates options.
File Schedule RC (or RC-A for aggregations) with your corporate excise return (Form 355/356). Attach federal Form 6765 if applicable; no pre-approval needed. Strike Tax handles documentation and filing.
Yes, stack state and federal credits on the same QREs for compounded savings. Massachusetts bases use state-sourced data. Strike Tax optimizes dual claims.
Credits offset 100% of the first $25,000 in excise plus 75% above, with a $456 minimum tax floor. Combined groups share one $25K threshold. Disallowed portions carry indefinitely.
ASC provides 10% (post-2020) on QREs exceeding 50% of the prior 3-year average—simpler for startups. The election is a longer-term choice; consult your tax advisor before changing. Strike Tax evaluates if ASC beats the regular method.
No; S corps apply credits entity-level against excise tax. Partnerships/LLCs do pass through via K-1. Strike Tax advises on entity impacts.
Maintain records for at least 3 years after filing (recommend 5–7 years): employee time logs, project descriptions, expense receipts, and organizational charts. Sampling allowed with DOR agreement. Strike Tax prepares audit-ready files.